Per Gerald Until positioned to uplist focus on
Post# of 1418
(Total Views: 272)
Posted On: 03/16/2022 1:11:00 PM
Per Gerald
Until positioned to uplist focus on key milestones: Tollovir Greek EUA, Tollovid retrospective customer data to support OTC, Videssa trial prep & LymPro final data. No big spend. Drive revs @provistadx COVID PCR+antibody sales & expand test menu, market Tollovid heavily. $TOMDF
https://twitter.com/G_Commish/status/15040813...w&s=19
Until positioned to uplist focus on key milestones: Tollovir Greek EUA, Tollovid retrospective customer data to support OTC, Videssa trial prep & LymPro final data. No big spend. Drive revs @provistadx COVID PCR+antibody sales & expand test menu, market Tollovid heavily. $TOMDF
https://twitter.com/G_Commish/status/15040813...w&s=19
(1)
(0)Todos Med Ltd. (TOMDF) Stock Research Links
Scroll down for more posts ▼